
OptimizeRx Corp (OPRX) Earnings Dates & Reports
OptimizeRx Corp (OPRX) Most Recent Earnings
Report DateAug 7, 2025
Period EndingQ2 2025
Est. EPS-$0.03
Actual EPS$0.24
EarningsBeat
OptimizeRx Corp (OPRX) Earnings
View the latest OptimizeRx Corp (OPRX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in OptimizeRx Corp (OPRX)
Order type
Buy in
Order amount
Est. shares
0 shares
OptimizeRx Corp (OPRX) Earnings per Share (EPS) History
Signup for full accessBrowse free
OptimizeRx Corp (OPRX) Latest Earnings
The value each OPRX share was expected to gain vs. the value each share gained.
OptimizeRx Corp (OPRX) reported its most recent earnings on Aug 7, 2025 for Q2 2025, posting earnings per share (EPS) of $0.24. This exceeded analysts' expectations of -$0.03 by 900.00%, marking a Beat.
For comparison, OptimizeRx Corp reported EPS of $0.02 in the same quarter last year.
The company is expected to announce its next earnings report on 11/12/2025, with analysts projecting an EPS of -$0.01.
OptimizeRx Corp (OPRX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 12, 2025 | -$0.01 | Next earnings call Nov. 12, 2025 | ||
Q2 2025Aug 7, 2025 | -$0.03 | $0.24 | -900.00% | |
Q1 2025May 12, 2025 | -$0.12 | $0.08 | -166.67% | |
Q4 2024Mar 12, 2025 | $0.27 | $0.30 | +11.11% | |
Q3 2024Nov 13, 2024 | $0.06 | $0.12 | +100.00% | |
OptimizeRx Corp (OPRX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the OptimizeRx Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 7, 2025 | — | — | — |
May 12, 2025 | — | — | — |
Mar 12, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
OptimizeRx Corp (OPRX) Earnings FAQs
OptimizeRx Corp (OPRX) last reported earnings on Aug 7, 2025 for Q2 2025, posting an EPS of $0.24, which Beat the estimate of -$0.03 by 900.00%.
For Q2 2025, OptimizeRx Corp (OPRX) reported an EPS of $0.24, exceeding analysts' estimate of -$0.03 by 900.00%.
For Q2 2025, OptimizeRx Corp (OPRX) Beat expectations with an actual EPS of $0.24 vs. an estimated EPS of -$0.03.
Following the last earnings report on Aug 7, 2025, OptimizeRx Corp (OPRX)'s stock price moved — from — to —.
The next OptimizeRx Corp (OPRX) earnings call is scheduled for Nov. 12, 2025, where executives will discuss financial results and outlook.